2014 Pharma and Biotech Trends in Review Like all industries, pharma and biotech are facing industry-specific changes coupled with disruptive events in the external global environment. In this article, Peter Young highlights details from Young & Partners’ “Pharma and Biotech Strategic, M&A, and Financial Trends Report,” which covers the first three quarters of 2014 and the outlook for the future... Read more
UK: Medical Innovation Bill Still Divisive The innovation debate remains a lively one in the UK, and Lord Saatchi’s Medical Innovation Bill is just one part of it. The Bill is intended to mitigate against so called ‘defensive’ medicine, where clinicians might not prescribe or undertake surgery that differs from the ‘standard’ because they fear prosecution, and seems to winning over some of its detractors... Read more
Ireland: Back in Business for Biopharma In the past five years, many a biopharma company has found that Ireland is an ideal candidate to drive its European growth. With the industry on something of a hot streak in recent years, high-growth biopharma companies have found Ireland’s mature healthcare workforce of more than 500,000 hard to ignore, writes Rory Mullen... Read more
In-Use Wearables to Treble in Three Years A new report by Juniper Research finds that fitness wearables in-use will almost treble by 2018, compared to an estimated 19 million in-use devices this year. Marylyn Donahue looks to future full of wearable ECGs, glucose monitors and even insulin pumps .... Read more
Toward 2015: A Pharm Exec Global Digest Special In the latest issue of the Pharm Exec Global Digest: Transparency in Europe 2015; Cloud Technology: A 5-Year Outlook; Warehousing and the Future of the HCV Treatment Landscape; and more .... Read more
Which of the following activities is your most important upcoming initiative?
